-Albert Oriol Researcher Activity Profile

Research Author Detailed Information 

Albert Oriol Publication Rate By Year

Albert Oriol has published 5 paper(s) in 2007, 4 paper(s) in 2008, for a total of 9 research publications in total.

Albert A Oriol Author Information

LAST NAME: oriol

FIRST NAME: albert

INITIALS: A

AFFILIATION:

Papers

Albert Oriol's Publication Record

1. [Neutropenic enterocolitis in adult patients with acute leukemia or stem cell transplant recipients: study of 7 cases.] Year Published: 2007
2. Advanced Stage Is the Most Important Prognostic Factor for Survival in Patients with Systemic Acquired Immunodeficiency Syndrome-Related Non-Hodgkin's Lymphoma Treated with CHOP and Highly Active Antiretroviral Therapy. Year Published: 2007
3. [Neutropenic enterocolitis in adult patients with acute leukemia or stem cell transplant recipients: study of 7 cases] Year Published: 2007
4. Advanced stage is the most important prognostic factor for survival in patients with systemic acquired immunodeficiency syndrome-related non-Hodgkin's Lymphoma treated with CHOP and highly active antiretroviral therapy. Year Published: 2007
5. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial. Year Published: 2008
6. High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma. Year Published: 2008
Department of Hematology, Hospital Clínic, IDIBAPS, Barcelona, Spain.
7. [Neutropenic enterocolitis in adult patients with acute leukemia or stem cell transplant recipients: study of 7 cases] Year Published: 2007
Servicio de Hematología Clínica. Institut Català d'Oncologia-Hospital Universitari Germans Trias i Pujol. Badalona. Barcelona. España. mbatlle@iconcologia.net
8. High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma. Year Published: 2008
9. Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression. Year Published: 2008
Hospital Universitario de Salamanca, Salamanca, Spain.